EAM Investors’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

EAM Investors’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-654,516	Closed	-$4.14M	–	325
2019 Q4	$4.14M	Buy	654,516 +539,742	+470%	+$3.17M	0.91%	9
2019 Q3	$483K	Sell	114,774 -723,486	-86%	-$3.09M	0.13%	227
2019 Q2	$3.9M	Sell	838,260 -25,324	-3%	-$118K	0.95%	4
2019 Q1	$4.58M	Buy	863,584 +262,640	+44%	+$1.2M	1.12%	3
2018 Q4	$2.22M	Buy	+600,944	New	+$2.11M	0.6%	38
2017 Q4	–	Sell	-780,635	Closed	-$2.3M	–	393
2017 Q3	$2.3M	Buy	780,635 +299,163	+62%	+$911K	0.31%	150
2017 Q2	$1.35M	Buy	+481,472	New	+$1.02M	0.22%	176
2015 Q1	–	Sell	-175,791	Closed	-$2.11M	–	450
2014 Q4	$2.11M	Sell	175,791 -54,456	-24%	-$827K	0.29%	157
2014 Q3	$3.94M	Sell	230,247 -32,903	-13%	-$478K	0.8%	2
2014 Q2	$3.18M	Sell	263,150 -18,921	-7%	-$179K	0.6%	14
2014 Q1	$2.38M	Buy	+282,071	New	+$2.28M	0.43%	57

Other funds holding BDSI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EAM Investors's BDSI Position: Q1 2020 in Review

EAM Investors sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2020, closing a stake of 654,516 shares — an estimated $4.14M sold.

EAM Investors first reported a position in BDSI in Q1 2014 and held it in 11 quarters. The position peaked at $4.58M in Q1 2019. 153 funds tracked by Wall St. Rank hold BDSI as of Q1 2020.

EAM Investors reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2020 after selling out during the quarter.
EAM Investors sold 654,516 BioDelivery Sciences International, Inc. shares in Q1 2020, an estimated $4.14M.
EAM Investors first reported a position in BioDelivery Sciences International, Inc. in Q1 2014 and held it in 11 quarters.
EAM Investors's BioDelivery Sciences International, Inc. position peaked at $4.58M in Q1 2019.
153 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2020.

Based on EAM Investors's 13F filing for Q1 2020, filed 13 May 2020.